| abstract |
A pharmaceutical composition comprising dipyridamole or a pharmaceutically acceptable salt thereof, acetylsalicylic acid (ASA) and an angiotensin II antagonist, selected from the group consisting of candesartan, eprosartan, irbesartan, losartan, telmisartan, valsartan, olmesartan and tasosartan, including their salts and their polymorphs, as a combined preparation for simultaneous, separate or sequential use. |